Annual EBIT
-$1.57 M
+$2.68 M+63.05%
31 December 2023
Summary:
Nephros annual earnings before interest & taxes is currently -$1.57 million, with the most recent change of +$2.68 million (+63.05%) on 31 December 2023. During the last 3 years, it has risen by +$1.17 million (+42.65%). NEPH annual EBIT is now -194.02% below its all-time high of $11.84 million.NEPH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$183.00 K
+$472.00 K+163.32%
01 September 2024
Summary:
Nephros quarterly earnings before interest & taxes is currently $183.00 thousand, with the most recent change of +$472.00 thousand (+163.32%) on 01 September 2024. Over the past year, it has increased by +$836.00 thousand (+128.02%). NEPH quarterly EBIT is now -95.36% below its all-time high of $3.94 million, reached on 31 December 2013.NEPH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$927.00 K
+$365.00 K+28.25%
01 September 2024
Summary:
Nephros TTM earnings before interest & taxes is currently -$927.00 thousand, with the most recent change of +$365.00 thousand (+28.25%) on 01 September 2024. Over the past year, it has increased by +$646.00 thousand (+41.07%). NEPH TTM EBIT is now -163.10% below its all-time high of $1.47 million, reached on 31 December 2013.NEPH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEPH EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +128.0% | +41.1% |
| 3 y3 years | +42.6% | +125.5% | +70.6% |
| 5 y5 years | +51.0% | +158.3% | +71.1% |
NEPH EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +63.0% | at high | +111.8% | at high | +78.2% |
| 5 y | 5 years | at high | +64.4% | at high | +111.3% | at high | +79.0% |
| alltime | all time | -194.0% | +80.4% | -95.4% | +103.4% | -163.1% | +89.5% |
Nephros EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $183.00 K(-163.3%) | -$927.00 K(-28.3%) |
| June 2024 | - | -$289.00 K(+72.0%) | -$1.29 M(-10.0%) |
| Mar 2024 | - | -$168.00 K(-74.3%) | -$1.44 M(-8.7%) |
| Dec 2023 | -$1.57 M(-63.0%) | -$653.00 K(+258.8%) | -$1.57 M(-3.9%) |
| Sept 2023 | - | -$182.00 K(-58.0%) | -$1.64 M(-39.4%) |
| June 2023 | - | -$433.00 K(+42.0%) | -$2.70 M(-10.2%) |
| Mar 2023 | - | -$305.00 K(-57.4%) | -$3.01 M(-29.3%) |
| Dec 2022 | -$4.26 M(+55.2%) | -$716.00 K(-42.5%) | -$4.26 M(-0.0%) |
| Sept 2022 | - | -$1.25 M(+68.2%) | -$4.26 M(+11.9%) |
| June 2022 | - | -$741.00 K(-52.3%) | -$3.81 M(-8.9%) |
| Mar 2022 | - | -$1.55 M(+116.4%) | -$4.18 M(+32.7%) |
| Dec 2021 | -$2.74 M(-37.9%) | -$718.00 K(-9.3%) | -$3.15 M(-0.8%) |
| Sept 2021 | - | -$792.00 K(-29.0%) | -$3.17 M(-5.9%) |
| June 2021 | - | -$1.11 M(+112.8%) | -$3.37 M(-13.2%) |
| Mar 2021 | - | -$524.00 K(-29.6%) | -$3.88 M(-12.0%) |
| Dec 2020 | -$4.42 M(+37.6%) | -$744.00 K(-24.8%) | -$4.42 M(+10.8%) |
| Sept 2020 | - | -$990.00 K(-39.2%) | -$3.99 M(+8.0%) |
| June 2020 | - | -$1.63 M(+54.2%) | -$3.69 M(+24.7%) |
| Mar 2020 | - | -$1.05 M(+236.0%) | -$2.96 M(-7.7%) |
| Dec 2019 | -$3.21 M(-1.1%) | -$314.00 K(-54.9%) | -$3.21 M(-11.5%) |
| Sept 2019 | - | -$696.00 K(-22.3%) | -$3.63 M(+5.2%) |
| June 2019 | - | -$896.00 K(-31.2%) | -$3.45 M(+7.5%) |
| Mar 2019 | - | -$1.30 M(+78.2%) | -$3.21 M(-1.2%) |
| Dec 2018 | -$3.25 M(+41.4%) | -$731.00 K(+41.1%) | -$3.25 M(+10.7%) |
| Sept 2018 | - | -$518.00 K(-20.8%) | -$2.93 M(-0.9%) |
| June 2018 | - | -$654.00 K(-51.3%) | -$2.96 M(-2.2%) |
| Mar 2018 | - | -$1.34 M(+222.8%) | -$3.02 M(+31.8%) |
| Dec 2017 | -$2.30 M(-19.7%) | -$416.00 K(-23.5%) | -$2.30 M(-7.1%) |
| Sept 2017 | - | -$544.00 K(-24.7%) | -$2.47 M(-3.8%) |
| June 2017 | - | -$722.00 K(+17.6%) | -$2.57 M(-3.1%) |
| Mar 2017 | - | -$614.00 K(+3.7%) | -$2.65 M(-7.3%) |
| Dec 2016 | -$2.86 M(-6.1%) | -$592.00 K(-7.6%) | -$2.86 M(-10.4%) |
| Sept 2016 | - | -$641.00 K(-20.4%) | -$3.19 M(+2.2%) |
| June 2016 | - | -$805.00 K(-2.1%) | -$3.12 M(-24.3%) |
| Mar 2016 | - | -$822.00 K(-10.9%) | -$4.12 M(+35.3%) |
| Dec 2015 | -$3.05 M(-55.8%) | -$923.00 K(+61.4%) | -$3.05 M(-3.6%) |
| Sept 2015 | - | -$572.00 K(-68.3%) | -$3.16 M(-1697.0%) |
| June 2015 | - | -$1.81 M(-811.0%) | $198.00 K(-106.0%) |
| Mar 2015 | - | $254.00 K(-124.5%) | -$3.32 M(-51.8%) |
| Dec 2014 | -$6.89 M | -$1.04 M(-137.2%) | -$6.89 M(+260.5%) |
| Sept 2014 | - | $2.79 M(-152.4%) | -$1.91 M(-64.0%) |
| June 2014 | - | -$5.32 M(+60.4%) | -$5.30 M(+742.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$3.32 M(-184.2%) | -$630.00 K(-142.9%) |
| Dec 2013 | $1.67 M(-151.3%) | $3.94 M(-750.2%) | $1.47 M(-141.2%) |
| Sept 2013 | - | -$606.00 K(-6.3%) | -$3.57 M(-6.5%) |
| June 2013 | - | -$647.00 K(-46.9%) | -$3.82 M(-2.7%) |
| Mar 2013 | - | -$1.22 M(+10.9%) | -$3.92 M(+20.3%) |
| Dec 2012 | -$3.26 M(+38.9%) | -$1.10 M(+28.7%) | -$3.26 M(+14.7%) |
| Sept 2012 | - | -$853.00 K(+13.1%) | -$2.84 M(+17.7%) |
| June 2012 | - | -$754.00 K(+35.4%) | -$2.42 M(+6.9%) |
| Mar 2012 | - | -$557.00 K(-18.0%) | -$2.26 M(-3.8%) |
| Dec 2011 | -$2.35 M(+24.3%) | -$679.00 K(+59.8%) | -$2.35 M(+3.3%) |
| Sept 2011 | - | -$425.00 K(-28.9%) | -$2.27 M(+1.4%) |
| June 2011 | - | -$598.00 K(-7.4%) | -$2.24 M(+11.5%) |
| Mar 2011 | - | -$646.00 K(+7.0%) | -$2.01 M(+6.3%) |
| Dec 2010 | -$1.89 M(-21.5%) | -$604.00 K(+53.7%) | -$1.89 M(+4.1%) |
| Sept 2010 | - | -$393.00 K(+7.4%) | -$1.81 M(-7.6%) |
| June 2010 | - | -$366.00 K(-30.6%) | -$1.97 M(-10.4%) |
| Mar 2010 | - | -$527.00 K(-0.4%) | -$2.19 M(-8.9%) |
| Dec 2009 | -$2.41 M(-64.2%) | -$529.00 K(-2.6%) | -$2.41 M(-14.6%) |
| Sept 2009 | - | -$543.00 K(-8.6%) | -$2.82 M(-22.9%) |
| June 2009 | - | -$594.00 K(-19.7%) | -$3.65 M(-35.7%) |
| Mar 2009 | - | -$740.00 K(-21.2%) | -$5.68 M(-15.4%) |
| Dec 2008 | -$6.72 M(-10.2%) | -$939.00 K(-31.9%) | -$6.72 M(-19.8%) |
| Sept 2008 | - | -$1.38 M(-47.5%) | -$8.38 M(-4.9%) |
| June 2008 | - | -$2.62 M(+47.7%) | -$8.81 M(+13.9%) |
| Mar 2008 | - | -$1.78 M(-31.7%) | -$7.74 M(+3.4%) |
| Dec 2007 | -$7.48 M(-6.9%) | -$2.60 M(+43.6%) | -$7.48 M(+5.2%) |
| Sept 2007 | - | -$1.81 M(+16.9%) | -$7.11 M(-1.3%) |
| June 2007 | - | -$1.55 M(+2.0%) | -$7.20 M(-8.2%) |
| Mar 2007 | - | -$1.52 M(-31.9%) | -$7.84 M(-2.5%) |
| Dec 2006 | -$8.03 M(+27.0%) | -$2.23 M(+17.1%) | -$8.04 M(+3.3%) |
| Sept 2006 | - | -$1.90 M(-13.1%) | -$7.78 M(+94.7%) |
| June 2006 | - | -$2.19 M(+27.5%) | -$4.00 M(+2.4%) |
| Mar 2006 | - | -$1.72 M(-12.9%) | -$3.90 M(+48.2%) |
| Dec 2005 | -$6.32 M(-17.3%) | -$1.97 M(-204.8%) | -$2.63 M(-3.2%) |
| Sept 2005 | - | $1.88 M(-189.8%) | -$2.72 M(-58.0%) |
| June 2005 | - | -$2.09 M(+366.7%) | -$6.49 M(+6.8%) |
| Mar 2005 | - | -$448.90 K(-78.2%) | -$6.07 M(+8.0%) |
| Dec 2004 | -$7.64 M(+53.1%) | -$2.06 M(+9.4%) | -$5.63 M(+57.8%) |
| Sept 2004 | - | -$1.88 M(+12.1%) | -$3.56 M(+112.1%) |
| June 2004 | - | -$1.68 M | -$1.68 M |
| Dec 2003 | -$4.99 M(+143.0%) | - | - |
| Dec 2002 | -$2.06 M(+369.3%) | - | - |
| Dec 2001 | -$437.90 K | - | - |
FAQ
- What is Nephros annual earnings before interest & taxes?
- What is the all time high annual EBIT for Nephros?
- What is Nephros quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Nephros?
- What is Nephros quarterly EBIT year-on-year change?
- What is Nephros TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Nephros?
- What is Nephros TTM EBIT year-on-year change?
What is Nephros annual earnings before interest & taxes?
The current annual EBIT of NEPH is -$1.57 M
What is the all time high annual EBIT for Nephros?
Nephros all-time high annual earnings before interest & taxes is $11.84 M
What is Nephros quarterly earnings before interest & taxes?
The current quarterly EBIT of NEPH is $183.00 K
What is the all time high quarterly EBIT for Nephros?
Nephros all-time high quarterly earnings before interest & taxes is $3.94 M
What is Nephros quarterly EBIT year-on-year change?
Over the past year, NEPH quarterly earnings before interest & taxes has changed by +$836.00 K (+128.02%)
What is Nephros TTM earnings before interest & taxes?
The current TTM EBIT of NEPH is -$927.00 K
What is the all time high TTM EBIT for Nephros?
Nephros all-time high TTM earnings before interest & taxes is $1.47 M
What is Nephros TTM EBIT year-on-year change?
Over the past year, NEPH TTM earnings before interest & taxes has changed by +$646.00 K (+41.07%)